Document Detail


The limited efficacy of exercise radionuclide ventriculography in assessing prognosis of women with coronary artery disease.
MedLine Citation:
PMID:  7484856     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Increasing numbers of women are undergoing stress testing for coronary artery disease evaluation. Limited study is available as to its efficacy in women. Four hundred nineteen patients with coronary artery disease (74 women and 345 men) referred for exercise radionuclide ventriculography between 1979 and 1986 were evaluated in a prospective cohort evaluation with 5-year follow-up. Exercise radionuclide ventriculographic variables were analyzed and compared between women and men. The prognostic efficacy of exercise radionuclide ventriculography was assessed separately for women and men among patients with coronary artery disease by Kaplan-Meier cumulative survival curves, univariate Cox regression analyses, and hierarchical stepwise Cox regression analyses. Overall, women demonstrated higher resting and peak left ventricular ejection fraction response to exercise than men. Ninety-six of 419 patients (23%) had cardiac events at 5-year follow-up. Although left ventricular response to exercise conveyed prognostic information in the combined and male populations (multivariate hierarchical analyses chi-square 11, p = 0.001 for delta left ventricular ejection fraction and chi-square 10, p = 0.002 for worsening exercise wall motion score), these variables were not found to be prognostically useful in women. Women with coronary artery disease demonstrated a worsened functional status, evidenced by greater compromise of exercise capacity, despite having less extensive anatomic disease than their male counterparts. We conclude that sex-related differences in left ventricular response to exercise limit the prognostic utility of exercise ventriculography in women with coronary artery disease.
Authors:
M Moriel; A Rozanski; J Klein; D S Berman; C N Merz
Related Documents :
6970516 - Serial exercise testing after coronary artery bypass surgery.
17558196 - Paraoxonase activity following exercise-based cardiac rehabilitation program.
11448656 - Exercise echocardiography for the prognostic stratification of patients with low pretes...
25333246 - Exercise is associated with a reduction in gestational diabetes mellitus.
18277196 - Left ventricular remodelling in patients with moderate systolic dysfunction after myoca...
12365846 - Preventing cumulative trauma injury carpal tunnel syndrome.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of cardiology     Volume:  76     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1995 Nov 
Date Detail:
Created Date:  1995-12-21     Completed Date:  1995-12-21     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1030-5     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Chi-Square Distribution
Cohort Studies
Coronary Disease / mortality,  physiopathology,  radionuclide imaging*
Exercise Test
Female
Follow-Up Studies
Gated Blood-Pool Imaging
Humans
Male
Middle Aged
Multivariate Analysis
Predictive Value of Tests
Prognosis
Prospective Studies
Regression Analysis
Sex Factors
Stroke Volume
Survival Rate
Grant Support
ID/Acronym/Agency:
17651//PHS HHS; 232HL07380/HL/NHLBI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous tra...
Next Document:  Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antia...